Romnee Clark

  • 303 Citations
  • 11 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Romnee Clark is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Pemetrexed Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Anthracyclines Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Chemoradiotherapy Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Folic Acid Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants 1999 2019


Zhang, Z., Clark, R., Perkins, S., Abonour, R., Srour, E., Dunn, K., Loehrer, P., Yiannoutsos, C., Field, L., Williams, S., Croop, J., Williams, D., Hawes, J., Jung, S., Cripe, L. & Cripe, L.

National Institutes of Health


Project: Research project

Research Personnel
Flow Cytometry

Publications 1994 2016

  • 303 Citations
  • 11 h-Index
  • 12 Article
3 Citations (Scopus)

Phase I study of lenalidomide and sorafenib inpatients with advanced hepatocellular carcinoma

Shahda, S., Loehrer, P., Clark, R., Spittler, A. J., Althouse, S. K. & Chiorean, E. G., Jun 1 2016, In : Oncologist. 21, 6, p. 664-665 2 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Immunologic Factors
19 Citations (Scopus)

Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancer

Chiorean, E. G., Schneider, B., Akisik, M., Perkins, S., Anderson, S., Johnson, C. S., DeWitt, J., Helft, P., Clark, R., Johnston, E. L., Spittler, A. J., Deluca, J., Bu, G., Shahda, S., Loehrer, P., Sandrasegaran, K. & Cardenes, H. R., Jun 1 2014, In : International Journal of Radiation Oncology Biology Physics. 89, 2, p. 284-291 8 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
radiation therapy
13 Citations (Scopus)

Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53

Chiorean, E. G., Sanghani, S., Schiel, M. A., Yu, M., Burns, M., Tong, Y., Hinkle, D. T., Coleman, N., Robb, B., Leblanc, J., Clark, R., Bufill, J., Curie, C., Loehrer, P. & Cardenes, H., Jul 2012, In : Cancer Chemotherapy and Pharmacology. 70, 1, p. 25-32 8 p.

Research output: Contribution to journalArticle

Rectal Neoplasms
Gene expression
17 Citations (Scopus)

Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): A phase I/II study from the hoosier oncology group

Jalal, S., Waterhouse, D., Edelman, M. J., Nattam, S., Ansari, R., Koneru, K., Clark, R., Richards, A., Wu, J., Yu, M., Bottema, B., White, A. & Hanna, N., Nov 2009, In : Journal of Thoracic Oncology. 4, 11, p. 1420-1424 5 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Disease Progression
Maximum Tolerated Dose
24 Citations (Scopus)

A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer

Llombart-Cussac, A., Martin, M., Harbeck, N., Anghel, R. M., Eniu, A. E., Verrill, M. W., Neven, P., De Grève, J., Melemed, A. S., Clark, R., Simms, L., Kaiser, C. J. & Ma, D., Jun 15 2007, In : Clinical Cancer Research. 13, 12, p. 3652-3659 8 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Drug Therapy
Confidence Intervals
Vitamin B 12